|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Intangibles | ||||||||||||||||||||
| Equipment, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Accrued liabilities - related party | ||||||||||||||||||||
| Accrued payroll taxes | ||||||||||||||||||||
| Customer deposits - related party | ||||||||||||||||||||
| Debt, current portion | ||||||||||||||||||||
| Debt, current portion, net of debt discount | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Debt, long-term portion, net of debt discount | ||||||||||||||||||||
| Debt, long-term portion | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and contingencies (Note 5) | ||||||||||||||||||||
| Commitments and contingencies (Note 5) | ||||||||||||||||||||
| Stockholders' deficit: | ||||||||||||||||||||
| Common stock, $0.001 par value; 1,000,000,000 shares authorized; 838,283,646 and 683,450,744 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Common stock issuable | ||||||||||||||||||||
| Common stock held in escrow | ||||||||||||||||||||
| Preferred stock Series A, $0.001 par value; 410 shares authorized; 3 issued and outstanding | ||||||||||||||||||||
| Preferred Stock Series A | ||||||||||||||||||||
| Preferred Stock Series B | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Preferred stock Series B, $.001 par value; 3,636,360 shares authorized; 2,727,270 issued and outstanding | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total liabilities and stockholders' deficit | ||||||||||||||||||||
Loading...
